Risk factors for ERCP-related complications: A prospective multicenter study

American Journal of Gastroenterology

Volumn 104, Issue 1, 2009, Pages 31-40

  Wang, Peng ^a   Li, Zhao Shen ^a   Liu, Feng ^a   Ren, Xu ^b   Lu, Nong Hua ^c   Fan, Zhi Ning ^d   Huang, Qiang ^e   Zhang, Xiao ^f   He, Li Ping ^g   Sun, Wen Sheng ^h   Zhao, Qiu ⁱ   Shi, Rui Hua ^j   Tian, Zi Bin ^k   Li, Yan Qing ^l   Li, Wen ^m   Zhi, Fa Chao ⁿ  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG PROVINCIAL HOSPITAL   (China)

^c NANCHANG UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e ANHUI PROVINCIAL HOSPITAL   (China)

^f HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^g FUJIAN PROVINCIAL HOSPITAL   (China)

^h Shandong Communication Hospital   (China)

ⁱ HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^j NANJING MEDICAL UNIVERSITY   (China)

^k QINGDAO UNIVERSITY   (China)

^l SHANDONG UNIVERSITY   (China)

^m TIANJIN UNION MEDICAL CENTER   (China)

ⁿ FIRST MILITARY MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGE DISTRIBUTION; ARTICLE; BILE DUCT OBSTRUCTION; CANNULATION; CHINA; CHOLANGITIS; CHOLECYSTITIS; CLINICAL TRIAL; DIVERTICULOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMYLASEMIA; LIVER CIRRHOSIS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEEDLE; PANCREAS HEMORRHAGE; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCALPEL; SEX DIFFERENCE; SPHINCTEROTOMY; TIME; VATER PAPILLA; MIDDLE AGED; ODDI SPHINCTER; PATHOPHYSIOLOGY;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; HYPERAMYLASEMIA; MALE; MIDDLE AGED; PANCREATITIS; RISK FACTORS; SPHINCTER OF ODDI;

EID: 60749121890     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.5     Document Type: Article

References (35)

1. Freeman ML. Adverse outcomes of ERCP. Gastrointest Endosc 2002;56:S273-82.
2. Freeman ML, Nelson DB, Sherman S et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-18.
3. Freeman ML, DiSario JA, Nelson DB et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-34.
4. Loperfido S, Angelini G, Benedetti G et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
5. Masci E, Toti G, Mariani A et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001;96:417-23.
6. Vandervoort J, Soetikno RM, Tham TCK et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002;56:652-6.
7. Cheng CL, Sherman S, Watkins JL et al. Risk factors for Post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006;101:139-47.
8. Williams EJ, Taylor S, Fairclough P et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007;39:793-801.
9. Dickinson RJ, Davies S. Post-ERCP pancreatitis and hyperamylasemia: the role of operative and patient factors. Eur J Gastroenterol Hepatol 1998;10:423-8.
10. Christoforidis E, Goulimaris I, Kanellos I et al. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors. Endoscopy 2002;34:286-292.
11. Andriulli A, Clemente R, Solmi L et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002;56:488-95.
12. Andriulli A, Leandro G, Niro G et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.
13. Behar J, Corazziari E, Guelrud M et al. Functional gallbladder and sphincter of Oddi disorders. Gas troenterology 2006;130:1498-509.
14. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984;25:756-9.
15. Cotton PB, Lehman G, Vennes JA et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-91.
16. Aronson N, Flamm CR, Bohn RL et al. Evidence - based assessment: patient, procedure, or operator factors associated with ERCP complications. Gastrointest Endosc 2002;56:S294-302.
17. Kawai K, Akasaka Y, Murakami K et al. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc 1974;20:148-51.
18. Cohen S, Bacon BR, Berlin JA et al. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, 14-16 January. Gastrointest Endosc 2002;56:803-9.
19. Friedland S, Soetikno RM, Vandervoort J et al. Bedside scoring system to predict the risk of developing pancreatitis following ERCP. Endoscopy 2002;34:483-8.
20. Haber GB. Prevention of post-ERCP pancreatitis. Gastrointest Endosc 2000;51:100-3.
21. Fogel EL, Eversman D, Jamidar P et al. Sphincter of Oddi dysfunction: pancreatobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002;34:280-5.
22. Masci E, Mariani A, Curioni S et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003;35:830-4.
23. Laugier R, Bernard JP, Berthezene P et al. Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly. Digestion 1991;50:202-ll.
24. Freeman ML, Guda NM. ERCP cannulation: a review of reported techniques. Gastrointest Endosc 2005;61:112-25.
25. Artifon ELA, Sakai P, Cunha JEM et al. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol 2007;102:2147-53.
26. Leila F, Bagnolo F, Colombo E et al. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc 2004;59:830-4.
27. Mehta SN, Pavone E, Barkun JS et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998;30:457-63.
28. Rabenstein T, Schneider HT, Bulling D et al. Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low dose anticoagulation treatment. Endoscopy 2000;32:10-9.
29. Tarnasky PR, Palesch YY, Cunningham JT et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998;115:1518-24.
30. Fazel A, Quadri A, Catalano MF et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003;57:291-4.
31. Singh P, Das A, Isenberg G et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004;60:544-50.
32. Sriram PVJ, Rao GV, Reddy DN. The precut - when, where and how? A review. Endoscopy 2003;35:S24-30.
33. Tang SJ, Haber GB, Kortan P et al. Precut papillotomy vs. persistence in difficult biliary cannulation: a prospective randomized trial. Endoscopy 2005;37:58-65.
34. Catalano MF, Linder JD, Geenen JE. Endoscopic transpancreatic papillary septotomy for inaccessible obstructed bile ducts: comparison with standard pre-cut papillotomy. Gastrointest Endosc 2004;60: 557-61.
35. Cooper ST, Slivka A. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterol Clin N Am 2007;36:259-76.